SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-004574
Filing Date
2019-01-08
Accepted
2019-01-08 15:35:37
Documents
3
Period of Report
2019-01-08
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d673508d8k.htm 8-K 28898
2 EXHIBIT 3.1 d673508dex31.htm EX-3.1 478679
3 GRAPHIC g673508g0108111129037.jpg GRAPHIC 1917
  Complete submission text file 0001193125-19-004574.txt   512367
Mailing Address BLOCK 2, MIESIAN PLAZA 50-58 BAGGOT STREET LOWER DUBLIN 2 L2 D02 HW68
Business Address BLOCK 2, MIESIAN PLAZA 50-58 BAGGOT STREET LOWER DUBLIN 2 L2 D02 HW68 353-1-609-6000
Shire plc (Filer) CIK: 0000936402 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37896 | Film No.: 19515874
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences